PUBLICATIONS · 31160249
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2019 Jul
- First author
- Judson I
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2019 Jul;20(7):901-903. doi: 10.1016/S1470-2045(19)30324-9.
- note
- Source null
- related pmid
- 31160250
- relationship
- Comment in
Authors and identifiers
- name
- Judson I
- type
- Author
- name
- Morden JP
- type
- Author
- name
- Kilburn L
- type
- Author
- name
- Leahy M
- type
- Author
- name
- Benson C
- type
- Author
- name
- Bhadri V
- type
- Author
- name
- Campbell-Hewson Q
- type
- Author
- name
- Cubedo R
- type
- Author
- name
- Dangoor A
- type
- Author
- name
- Fox L
- type
- Author
- name
- Hennig I
- type
- Author
- name
- Jarman K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Judson I
- type
- Author
- name
- Morden JP
- type
- Author
- name
- Kilburn L
- type
- Author
- name
- Leahy M
- type
- Author
- name
- Benson C
- type
- Author
- name
- Bhadri V
- type
- Author
- name
- Campbell-Hewson Q
- type
- Author
- name
- Cubedo R
- type
- Author
- name
- Dangoor A
- type
- Author
- name
- Fox L
- type
- Author
- name
- Hennig I
- type
- Author
- name
- Jarman K
- type
- Author
- bibliography ids
- nci-bib-806f9331eeeb098213d5b462
- book metadata
- content sha256
- 721d2653d8a86ce8086855fb7facb44931a4b509b7657ac6156adbe3d8da4706
- document type
- citation
- dois
- 10.1016/S1470-2045(19)30215-3
- electronic publication date
- display
- 2019 May 31
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31160249
- immutable id
- pubmed:31160249@721d2653d8a86ce8086855fb7facb44931a4b509b7657ac6156adbe3d8da4706
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 7
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1023-1034
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2019 Jul;20(7):901-903. doi: 10.1016/S1470-2045(19)30324-9.
- note
- Source null
- related pmid
- 31160250
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 31160249
- provenance
- batch id
- 23ffe1e2a9e160b6dca0
- provider
- NCBI PubMed ESummary
- record sha256
- f198c76869ddb29dc91f1200f40a55f1f25d8c8d2fe97c693d72cd87bb6079b9
- response sha256
- d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
- retrieved at
- 2026-09-09T23:47:44.690737+00:00
- publication date
- display
- 2019 Jul
- precision
- month
- year
- 2019
- publication types
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Preserved source evidence · Not medical advice
Triangle